Quaker Chemical (KWR) On Executive Exit And A Valuation Story Still Up For Debate

Quaker Chemical (KWR) is back on investors' radar after the company disclosed that Jeewat Bijlani will exit his role as Executive Vice President, Global Specialty and Chief Growth Officer, effective September 30, 2026.

The announcement comes after a choppy stretch for Quaker Chemical, with the share price down 9.8% over the past month, up 8.1% over 90 days, and delivering a 1-year total shareholder return of 13.0%, while the 5-year total shareholder return remains down 34.5%. This points to momentum that has picked up recently, albeit from a weaker long-term base.

Spot potential rebound candidates around Quaker Chemical by scanning our curated 31 high quality undervalued stocks, which combines cash generation with balance sheet strength.

After a sharp monthly pullback but a stronger 1 year gain, Quaker Chemical now asks a simple question of investors. Do the current terms still tilt the risk reward toward buyers, or has the easy upside already been used up?

Most Popular Narrative: 18.3% Undervalued

The most followed narrative pegs Quaker Chemical's fair value at $189.71 versus a last close of $155.08. That gap hinges on a specific growth and margin story that not every investor will agree with.

Significant capital investment (e.g., new China facility, Thailand plant upgrade, enhanced manufacturing capabilities) and integration of the Dipsol acquisition expand Quaker's footprint in high-growth Asia/Pacific regions, positioning the company to capitalize on manufacturing reshoring, structural growth in Asian auto/e-mobility markets, and local-for-local supply strategies, drivers of future revenue and gross margin expansion.

Read the complete narrative. Read the complete narrative.

Want to see what kind of revenue glide path, margin lift, and future earnings multiple need to line up for that fair value to stack up? The narrative leans heavily on a specific combination of volume gains in specialty chemistries, rising profitability, and a lower earnings multiple than many investors might expect for that profile.

The fair value of $189.71 draws on a discount rate of about 7.8%, modest top line expansion and a sharp step up in profitability over time. It leans on expectations that Quaker Chemical can compound earnings faster than its revenue by pushing higher margin products, squeezing more efficiency from its cost base, and keeping capital allocation focused on bolt on deals and buybacks rather than stretching the balance sheet.

That story also assumes the firm continues to win in segments like automation, energy storage and greener industrial processes, while its newer footprint in Asia/Pacific supports steadier volumes despite more uneven conditions in regions such as EMEA. The implied future P/E in the narrative sits below the current industry level, which means the upside case is not only about growth but also about the market being willing to accept a more modest multiple on higher earnings.

Result: Fair Value of $189.71 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

Still, that upside story for Quaker Chemical quickly weakens if EMEA margin pressure proves sticky or if elevated leverage restricts buybacks, acquisitions, and reinvestment.

Find out about the key risks to this Quaker Chemical narrative.

Another View On Quaker Chemical’s Valuation

The story looks different when you move away from the narrative fair value and focus on what investors are actually paying for Quaker Chemical today. The stock trades on a P/E of 27.4x, while the fair ratio is 23.6x and the US Chemicals industry sits at 23.2x, with peers around 25.1x.

That gap suggests buyers are already paying a premium for Quaker Chemical relative to both the sector and where the fair ratio implies the multiple could drift over time. The question is simple: Are you comfortable paying above those anchors, or do you want a wider margin for error first?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Mixed messages on Quaker Chemical so far? Treat this as your prompt to move fast, review the underlying figures, and lean on the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Quaker Chemical?

If Quaker Chemical has you thinking more broadly about opportunities, it is worth widening your search now instead of waiting for the next headline to move the market.

• Target potential value opportunities early by scanning our curated list of 31 high quality undervalued stocks that blend resilient cash flows with disciplined pricing power.
• Prioritise resilience by reviewing a list of solid balance sheet and fundamentals (24 results) so you can focus on businesses that carry less financial strain when conditions turn tougher.
• Hunt for under-the-radar ideas through a 17 high quality undiscovered gems before the wider market turns its attention to them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com